2080 Century Park E #803 Los Angeles, CA 90067
M-F, 8:30 AM to 5:00 PM
BGB-11417-301
The main objective of this study is to compare the efficacy of sonrotoclax plus zanubrutinib versus venetoclax plus obinutuzumab in participants with chronic lymphocytic leukemia (CLL)